Estrogen-related medications for menopause will no longer carry broad black-box warnings, Marty Makary, commissioner of the US Food and Drug Administration (FDA), announced last week, bypassing the regulatory agency’s typical process and,…
Continue Reading
News Source: www.theguardian.com

Leave a Reply